- This event has passed.
Neuromodulation, Neuroscience, and Digital Health
Patient-centric Innovation in Chronic Pain Therapies
June 25, 2020 (PDT) @ 5:30 pm – 6:30 pm
Join CEO and Founder of Neurovations, Dr. Eric Grigsby, and the Director of R&D Applied Research at Abbott Neuromodulation, Dr. Erika Ross, for an in-depth discussion on patient-centric innovations in chronic pain therapies. During this webinar, Dr. Ross will discuss her team’s research in building patient-centric neuromodulation therapies and discuss ways in which digital health can be leveraged to provide truly patient-centric chronic pain neuromodulation therapies.
About Eric Grigsby, MD, MBA
Dr. Eric Grigsby is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.
Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.
The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.
Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.
About Erika Ross, Phd
Erika is the Director of Applied Research at Abbott Neuromodulation, leading applied research strategy, external partnerships, portfolio, and execution. Applied research includes computational modeling, pre-clinical, feasibility, and clinical safety trials that feed new products and indications.
Prior to her role at Abbott, Erika was the Neuroscience Director at Cala Health, a Stanford Biodesign incubated start-up that has been developing a non-invasive, digitally-enabled neuromodulation solution for Essential Tremor patients. She held roles of increasing leadership at Cala Health as the company completed development and prepared for commercialization and played a major role in developing their digital health architecture and team.
Prior to Cala Health, Erika was an Assistant Professor in Neurologic Surgery and the Deputy Director of the Surgical Device Innovation Accelerator at the Mayo Clinic where she developed invasive and non-invasive solutions for unmet patient needs in the neuromodulation and other surgical practice areas.